Analyst Information

 

Danielle Brill, Pharm.D.

Sr. Research Analyst

Danielle Brill, Pharm.D.

Danielle Brill is a vice president and senior research analyst at Piper Jaffray covering biotechnology. Prior to joining Piper Jaffray in 2018, Brill spent three years at Needham and Company, where she also covered biotechnology and biopharmaceuticals. Before her career on Wall Street, Brill worked as a clinical pharmacist at Mount Sinai Hospital in New York City. She also worked in research laboratories focused on the development of novel therapeutics for lymphoid malignancies at Columbia Presbyterian and NYU Langone. Brill received her bachelor's degree from Michigan State University and earned her Pharm.D. from Ernest Mario School of Pharmacy at Rutgers, where she graduated summa cum laude.

Associates:

Nirav Shelat, Ph.D.
Research Analyst
Universe Coverage:
Healthcare:   Biotechnology
ACADACADIA Pharmaceuticals Inc.
XLRNAcceleron Pharma Inc.
ALDRAlder BioPharmaceuticals, Inc.
ALKSAlkermes Plc
FGENFibroGen, Inc.
GBTGlobal Blood Therapeutics, Inc.
GLYCGlycoMimetics, Inc.
GWPHGW Pharmaceuticals plc
MNTAMomenta Pharmaceuticals, Inc.
MORMorphoSys AG
SAGESage Therapeutics, Inc.
SRPTSarepta Therapeutics, Inc.
QUREuniQure N.V.
ZGNXZogenix, Inc.